Wild type ATXN1 was recently shown to have a protective role in regulating severity of experimental autoimmune encephalomyelitis (EAE), a well-established mouse model for Multiple sclerosis (MS). This evidence concerns the gene ATXN1 and experimental autoimmune encephalomyelitis.